Advancing Addiction Treatment: Building Knowledge of Substance Use and Specialty Topics
Advancing Addiction Treatment: Building Knowledge of Substance Use and Specialty Topics is a comprehensive training series aimed at advancing addiction treatment among health care professionals. This series consists of trainings covering 18+ topics. You can attend all sessions or select specific ones.
Foundational topics in this series include an introduction to substance use disorders (SUDs) and stigma, screening for SUDs, motivational interviewing, harm reduction, and medications for opioid use disorder (MOUD). Clinically focused sessions will review alcohol, benzodiazepine, and stimulant use disorders, in addition to MOUD implementation strategies, co-occurring disorders, and medical considerations for persons using substances. Population-specific trainings will discuss SUD as it relates to adolescents and young adults, older adults, peripartum persons, and those with a brain injury. Specialty topics include cannabis, criminal-legal involvement, overdose education and naloxone distribution, pain management, lab testing/toxicology screening, and regulatory issues relating to MOUD.
Screening, Assessment, and Treatment of Substance Use Disorders
This training will provide evidence-based recommendations and guidance for screening for substance use disorders.
As shortened version of Grayken TTA's Addiction 101 training, this 30-minute training provides an overview of the disease model of addiction, the overdose epidemic, stigma, and evidence-based treatments for persons with substance use disorder.
This two-hour course is designed to provide prescribers, including pharmacists, with the skills and education necessary to prescribe medications for opioid use disorder (MOUD). Topics include initial assessment, initiation of buprenorphine, injectable medications, visit management, monitoring, and strategies to reduce harm associated with continued use.
This training fulfills the DEA's 8-hour training requirement for prescribers
Medical professionals with prescriptive authority and nurses who support them looking to increase provision of care for patients with opioid use disorder.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
Funding for Grayken Center for Addiction TTA is provided by:
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.